These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 7541452)

  • 1. Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.
    Tirelli U; Errante D; Dolcetti R; Gloghini A; Serraino D; Vaccher E; Franceschi S; Boiocchi M; Carbone A
    J Clin Oncol; 1995 Jul; 13(7):1758-67. PubMed ID: 7541452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors.
    Lévy R; Colonna P; Tourani JM; Gastaut JA; Brice P; Raphaël M; Taillan B; Andrieu JM
    Leuk Lymphoma; 1995 Feb; 16(5-6):451-6. PubMed ID: 7540459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF.
    Errante D; Gabarre J; Ridolfo AL; Rossi G; Nosari AM; Gisselbrecht C; Kerneis Y; Mazzetti F; Vaccher E; Talamini R; Carbone A; Tirelli U
    Ann Oncol; 1999 Feb; 10(2):189-95. PubMed ID: 10093688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients. The Italian Cooperative Group on AIDS and Tumors (GICAT).
    Errante D; Tirelli U; Gastaldi R; Milo D; Nosari AM; Rossi G; Fiorentini G; Carbone A; Vaccher E; Monfardini S
    Cancer; 1994 Jan; 73(2):437-44. PubMed ID: 7507401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchronous presentation of Epstein-Barr virus-associated Hodgkin's disease and adult T-cell leukemia/lymphoma (ATLL) in a patient from an endemic area of ATLL.
    Hayashi T; Yamabe H; Haga H; Akasaka T; Kadowaki N; Ohno H; Okuma M; Fukuhara S
    Int J Hematol; 1995 Jun; 61(4):215-22. PubMed ID: 8547610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial.
    Somers R; Carde P; Henry-Amar M; Tarayre M; Thomas J; Hagenbeek A; Monconduit M; de Pauw BE; Breed WP; Verdonck L
    J Clin Oncol; 1994 Feb; 12(2):279-87. PubMed ID: 7509381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-related Hodgkin's disease. Report of nine cases.
    Novati S; Malfitano A; Sacchi P; Patruno SF; Tornari PM; Rondanelli EG
    Haematologica; 1993; 78(1):34-7. PubMed ID: 7684010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease.
    Dolcetti R; Zancai P; De Re V; Gloghini A; Bigoni B; Pivetta B; De Vita S; Carbone A; Boiocchi M
    Blood; 1997 Mar; 89(5):1723-31. PubMed ID: 9057656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
    Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
    Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.
    Chisesi T; Bellei M; Luminari S; Montanini A; Marcheselli L; Levis A; Gobbi P; Vitolo U; Stelitano C; Pavone V; Merli F; Liberati M; Baldini L; Bordonaro R; Pesce EA; Federico M
    J Clin Oncol; 2011 Nov; 29(32):4227-33. PubMed ID: 21990405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group.
    Gobbi PG; Pieresca C; Federico M; Di Renzo N; Narni F; Iannitto E; Grignani G; Cavanna L; Avanzini P; Partesotti G
    J Clin Oncol; 1993 Apr; 11(4):712-9. PubMed ID: 7683044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT).
    Monfardini S; Tirelli U; Vaccher E; Foà R; Gavosto F
    Ann Oncol; 1991 Feb; 2 Suppl 2():201-5. PubMed ID: 1710920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
    Lichtman SM; Brody J; Kaplan MH; Susin M; Koduru P; Goh JC
    Leuk Lymphoma; 1993 Mar; 9(4-5):393-8. PubMed ID: 7688628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study.
    Carbone A; Dolcetti R; Gloghini A; Maestro R; Vaccher E; di Luca D; Tirelli U; Boiocchi M
    Hum Pathol; 1996 Feb; 27(2):133-46. PubMed ID: 8617454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin lymphoma among patients infected with HIV in post-HAART era.
    Tanaka PY; Pessoa VP; Pracchia LF; Buccheri V; Chamone DA; Calore EE
    Clin Lymphoma Myeloma; 2007 Mar; 7(5):364-8. PubMed ID: 17562247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.
    Hentrich M; Berger M; Wyen C; Siehl J; Rockstroh JK; Müller M; Fätkenheuer G; Seidel E; Nickelsen M; Wolf T; Rieke A; Schürmann D; Schmidmaier R; Planker M; Alt J; Mosthaf F; Engert A; Arasteh K; Hoffmann C
    J Clin Oncol; 2012 Nov; 30(33):4117-23. PubMed ID: 23045592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease.
    Murray PG; Billingham LJ; Hassan HT; Flavell JR; Nelson PN; Scott K; Reynolds G; Constandinou CM; Kerr DJ; Devey EC; Crocker J; Young LS
    Blood; 1999 Jul; 94(2):442-7. PubMed ID: 10397711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data.
    Prosnitz LR; Farber LR; Kapp DS; Scott J; Bertino JR; Fischer JJ; Cadman EC
    J Clin Oncol; 1988 Apr; 6(4):603-12. PubMed ID: 2451712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.
    Castillo JJ; Bower M; Brühlmann J; Novak U; Furrer H; Tanaka PY; Besson C; Montoto S; Cwynarski K; Abramson JS; Dalia S; Bibas M; Connors JM; Furman M; Nguyen ML; Cooley TP; Beltran BE; Collins JA; Vose JM; Xicoy B; Ribera JM;
    Cancer; 2015 Feb; 121(3):423-31. PubMed ID: 25251326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
    Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
    J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.